Randomized Comparative Clinical Study of Virechana Karma & Dhanyamla Sarvang Dhara in the Management of Sthaulya w. s. r. to Obesity

Authors

  • Vandana Chauhan M.D. Scholar, Department of Panchakarma, Rishikul Campus, Uttarakhand Ayurved University, Haridwar, Uttarakhand, India
  • Alok Kumar Srivastava Associate Professor, Department of Panchakarma, Uttarakhand Ayurved University, Dehradun, Uttarakhand, India
  • Parul Sharma Assistant Professor, Department of Panchakarma, Rishikul Campus, Uttarakhand Ayurved University, Haridwar, Uttarakhand, India

Keywords:

Ayurveda, Dhanyamla Sarvang Dhara, obesity, Panchakarma, Sthaulya, Virechana Karma

Abstract

Modernization, affluence, science, and technological development leads to still more sedentary lifestyles, which lead to many disorders in which obesity is considered as a multifactorial disease. The World Health Organization (WHO) recognized obesity as one of the most serious public health problems of the 21st century. Obesity can be defined as abnormal or excessive fat accumulation that presents a risk to health. Obesity is a physiological, psychological, and social disorder, commonly caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility. Women are mainly affected as compared to men. In Ayurveda, obesity is correlated with Sthaulya and Medorog and also categorized in Santarpanjanya Vikaar (over nourishment of body). Modern science treatment includes dietary changes, physical exercise, and other drugs which has their own side effects. But Ayurveda is a ray of hope and is frequently sought by the public. Ayurveda consists of daily internal medications, doing fasts in the form of a light diet, exercise, and Shodhan Chikitsa which comprises of Panchakarma therapy, which is the most effective, safer, and better cure of the disease. Based on the hypothesis, the present study was conducted on the basis of inclusion and exclusion criteria after inspection of 40 patients in two groups that is, Virechana Karma and Dhanyamla Sarvang Dhara. Treatment was given for 60 days along with a follow-up period of 30 days. Patients were assessed on the basis of subjective and objective parameters. Both the interventions were almost equally effective in some parameters, but Dhanyamla Sarvang Dhara had better results than Virechana Karma in the overall improvement of the patients.

Author Biographies

  • Vandana Chauhan, M.D. Scholar, Department of Panchakarma, Rishikul Campus, Uttarakhand Ayurved University, Haridwar, Uttarakhand, India
    P.g scholar Dept.of panchakarma
  • Alok Kumar Srivastava, Associate Professor, Department of Panchakarma, Uttarakhand Ayurved University, Dehradun, Uttarakhand, India

     

    HOD

    Department of Panchkarma

  • Parul Sharma, Assistant Professor, Department of Panchakarma, Rishikul Campus, Uttarakhand Ayurved University, Haridwar, Uttarakhand, India

    Assistant Professor

    Department of Panchkarma

References

Knight JA. Diseases and Disorders Associated with Excess Body Weight. Ann Clin Lab Sci. 2011; 41(2): 107—121p.

Hruby A, Hu FB. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2015; 33(7): 673–689p.

World Health Organization. Obesity and Overweight Fact sheet N°311. Geneva: WHO; 2015 (Retrieved on 2016 Feb 2).

Girdhar S, Sharma S, Chaudhary A, Bansal P, Satija M. An Epidemiological Study of Overweight and Obesity Among

Women in an Urban Area of North India. Indian J Community Med. 2016; 41(2): 154–157p.

World Health Organization. Technical report series 894: Obesity: Preventing and managing the global epidemic. Geneva: WHO; 2000. ISBN 978-92-4-120894-9.

"Obesity and overweight Fact sheet N°311". WHO. January 2015. Retrieved 2 February 2016.

Albuquerque D, Nóbrega C, Manco L, Padez C. The contribution of genetics and environment to obesity. British Medical Bulletin. 2017; 123(1): 159–173p. Available from: https://doi.org/10.10 93/bmb/ldx022

Wilborn C, Beckham J. Obesity: Prevalence, Theories, Medical Consequences, Management, and Research. J Int Soc Sports Nutr. 2005; 2(2): 4–31p.

Sweeting HN. Measurement and definitions of obesity in childhood and adolescence: A field guide for the uninitiated. Nutr J. 2007; 6: 32p.

Ahima RS, Antwi DA. Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am. 2008; 37(4): 811–823p.

Bertin E. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on the visceral fat amount in type 2 diabetic patients. Diabetes Metab. 2000; 26(3): 178–182p.

Shastri RD (Ed.); Shastri KN, Chaturvedi GN (elaborated Vidyotini Hindi commentary). Charaka Samhita of Agnivesha, revised by Charaka and Drdhabala, with an introduction by Vaidya-Samrata Sri Satya Narayana Shastri Part-1. Varanasi, India: Chaukhamba Bharti Academy; Reprint-2009. Cha.Su. 21/3.

Shastri RD (Ed.); Shastri KN, Chaturvedi GN (elaborated Vidyotini hindi commentary). Charaka Samhita of Agnivesha, revised by Charaka and Drdhabala, with introduction by Vaidya-Samrata Sri Satya Narayana Shastri Part-1. Varanasi, India: Chaukhamba Bharti Academy; Reprint-2009. Cha.viman 3/43.

Shastri RD (Ed.); Shastri KN, Chaturvedi GN (elaborated Vidyotini hindi commentary). Charaka Samhita of Agnivesha, revised by Charaka and Drdhabala, with introduction by Vaidya-Samrata Sri Satya Narayana Shastri Part-1. Varanasi, India: Chaukhamba Bharti Academy; Reprint-2009. Cha.chi. 28/15. 572p.

Deva RRK. ShabdaKalpadruma, part 3, 3 ed, PB No 8. Varanasi, India: Chowkhamba Sanskrit Series Office; 1967. 709p.

Ranasinghe S, Ediriweera S. A pharmacological appraisal of Dhanyamla. IAMJ. 2015; 3(3): 787–797p. ISSN -23205091

Gupta N, Mangal G. A conceptual study of shirodhara procedure. Int J Res Ayurv Pharmacy. 2019; 10(3): 10–12p.

Hedge PL, Harini A. A text book of DravyagunaVijnana (according to the syllabus of Central Council of Indian Medicine), Vol 1st, chapter 5. New Delhi, India: Chaukhambha Publications; 2011. 230p.

Hedge PL, Harini A. A text book of DravyagunaVijnana (according to the syllabus of Central Council of Indian Medicine), Vol 1st, chapter 7. New Delhi, India: Chaukhambha Publications; 2011. 309p.

Hedge PL, Harini A. A text book of DravyagunaVijnana (according to the syllabus of Central Council of Indian Medicine), Vol 1st, chapter 5. New Delhi, India, India: Chaukhambha Publications; 2011. 231–232p.

Shastri RD (Ed.); Shastri KN, Chaturvedi GN (elaborated Vidyotini hindi commentary). Charaka Samhita of Agnivesha, revised by Charaka and Drdhabala, with introduction by Vaidya-Samrata, Part-1. Varanasi, India: Chaukhamba Bharti Academy; 2009. Cha.Su. 26/43

Bhisagacarya HSSP (Ed.). Ashtanga Hridaya with the commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri. Varanasi, India: Chaukhamba Orientalia; 2010. A.H.Su.1/18-Himadri.

Acharya JT (Ed.). Sushruta Samhita - Nibandhasangraha Commentary of Shri Dalhanacarya, part 1st, 7th Edition. Varanasi, India: Chaukhamba Orientalia; 2012. Su.Su. 46/419

Acharya JT (Ed.). Sushruta Samhita - Nibandhasangraha Commentary of Shri Dalhanacarya, Part 1st, 7th Edition. Varanasi, India: Chaukhamba Orientalia; 2012. Su.Su. 46/516

Hedge PL, Harini A. A text book of DravyagunaVijnana (according to the syllabus of Central Council of Indian Medicine), Vol 1, Chapter 4. New Delhi, India: Chaukhambha Publications; 2011. 167p.

Downloads

Published

2020-12-30

Issue

Vol. 7 No. 3 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.